Hyperlipidemias Terminated Phase 1 Trials for Telmisartan (DB00966)

Also known as: Hyperlipidemia / Hyperlipemia / Hyperlipidaemia / Hyperlipaemia / Hyperlipidemia, unspecified / Lipidemia / Hyperlipidaemia NOS

IndicationStatusPhase
DBCOND0031916 (Hyperlipidemias)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02608242PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and RosuvastatinTreatment